Big Acquisitions, Small Standards? The Truth About Recent Supplement Buyouts
Over the past several years, multinational conglomerates best known for synthetic detergents, artificial fragrances, heavy household chemicals, and corn syrup-laden processed foods have been buying up clean, high-purity supplement brands like limited-edition sneakers. For those of us who prioritize clean living, watching a trusted wellness brand get absorbed by a company whose core portfolio relies on industrial chemical formulations feels like a massive philosophical clash.
The latest headline-grabber is Procter & Gamble’s agreement earlier this week to acquire Thorne. Long considered a gold standard in practitioner-trusted, science-backed formulas, Thorne is now joining the same corporate umbrella that produces Tide, Crest, and Febreze.
It is completely valid to feel distrustful when a company dedicated to non-toxic purity is bought by a corporation whose everyday products rely on ingredients many of us actively avoid in our homes. While the short-term reality is that nothing in Thorne’s current inventory has changed overnight, the long-term culture clash is precisely why I am keeping a watchful eye on the situation.
Thorne joins a growing list of respected supplement companies that have been acquired by major consumer conglomerates:
Procter & Gamble (P&G)
- Thorne
- New Chapter
- Align Probiotic
- Metamucil
Nestlé Health Science
- Pure Encapsulations
- Garden of Life
- Solgar
- Douglas Laboratories
- Vital Proteins
- Orgain
- Nuun
- Persona Nutrition
- Nature’s Bounty
- Osteo Bi-Flex
- Puritan’s Pride
Unilever
- Liquid I.V.
- Nutrafol
- OLLY
- Onnit
- Grüns
When product quality slips after a buyout, it usually happens behind the scenes in three specific areas. Parent companies often look for cost efficiencies by swapping out active bio-available nutrients for cheaper generic alternatives, introducing synthetic binders or flow agents to accommodate high-speed manufacturing lines, or cutting back on rigorous third-party auditing.
Pure Encapsulations serves as a helpful case study showing that buyouts do not automatically trigger these downgrades. Since joining Nestlé, the company has largely maintained its clean formulations, hypoallergenic manufacturing standards, and practitioner focus without noticeable backsliding.
Despite occasional success stories, it is completely understandable to prefer independent companies whose entire mission aligns with low-toxicity, clean living. For clients who prefer to avoid multinational parent corporations altogether on principle, I maintain a running list of fully independent, practitioner-grade alternatives.
As a holistic nutrition professional, I evaluate brands based on hard evidence rather than corporate ownership alone. My focus stays strictly on ingredient purity, active bio-forms, full label transparency, and – most importantly – real-world clinical results.
I monitor label changes closely and talk constantly with fellow practitioners about manufacturing shifts and what we’re noticing in practice and clinical outcomes. Rest assured, the moment someone notices an added filler or a drop in clinical efficacy, word spreads like wildfire among clinicians.
There is no need to panic-cancel your routines or toss the bottles currently sitting on your counter. I will continue doing the homework, tracking Thorne’s formulations as the integration unfolds, and letting you know immediately if it is time to pivot.